Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.
Wegovy HD Side Effects: What Actually Changes at the 7.2 mg Dose?
By The RX Index Editorial Team — . Side-effect figures come from the FDA-approved Wegovy Prescribing Information (revised March 2026). Educational information, not medical advice.
Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
Wegovy HD side effects are mostly the same ones people already know from regular Wegovy — nausea, vomiting, constipation, stomach pain, tiredness, headache, dizziness, hair loss, and gas. The 7.2 mg dose makes those a little more common. But one side effect jumps a lot: dysesthesia, a word for odd skin feelings like tingling, burning, or a “sunburn” feeling. In the FDA's own trials, 22% of people on Wegovy HD reported it, versus 6% on the 2.4 mg dose. The part that surprises people most: it isn't dangerous for everyone, but ignoring it is — because the people who changed nothing mostly didn't recover by the trial's end.
What we actually verified (and when)
- • Side-effect numbers come from Table 4 of the FDA-approved Wegovy Prescribing Information (revised March 2026). Verified .
- • Dysesthesia recovery numbers come from the same FDA label's dysesthesia section. Verified .
- • Weight-loss numbers come from the STEP UP trial that led to the 7.2 mg approval (American Diabetes Association, June 2025).
- • The $399/month self-pay price is listed on NovoCare and Wegovy.com. NovoCare's coverage tool currently states there is no insurance coverage for Wegovy injection 7.2 mg. Verified .
- • We are an independent comparison resource. Novo Nordisk did not pay us to write this.
Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
Wegovy HD vs Wegovy 2.4 mg, at a glance
We took the FDA's numbers for placebo, the 2.4 mg dose, and the 7.2 mg HD dose and lined them up so you can see what actually changes when you step up — because that's the real question.
| Side effect | Wegovy HD 7.2 mg | Wegovy 2.4 mg | What changed? |
|---|---|---|---|
| Nausea | 39% | 35% | A little higher |
| Vomiting | 22% | 16% | Meaningfully higher |
| Dysesthesia (skin feelings) | 22% | 6% | The big jump |
| Constipation | 20% | 19% | Almost the same |
| Stomach pain | 12% | 9% | A little higher |
Source: FDA-approved Wegovy Prescribing Information, Table 4. Full 10-row version below.
The short version: stepping up to 7.2 mg mostly raises your odds of skin sensations and a bit more vomiting — not your odds of quitting because of side effects, which held steady in the trial. The serious warnings still apply at every dose.
▶ Build my Wegovy HD side-effect discussion plan. Answer a few quick questions about your dose, your symptoms, and your history. You'll get a printable list of what to ask your prescriber — and a flag if anything you mention should be checked sooner. It doesn't diagnose you and doesn't replace your doctor. Free. Takes about a minute.
Start the discussion builder →What are the most common Wegovy HD side effects?
The most common Wegovy HD side effects, from FDA trial data, are nausea (39%), vomiting (22%), dysesthesia or skin sensations (22%), constipation (20%), and stomach pain (12%), followed by tiredness, headache, dizziness, hair loss, and gas. These are the same categories seen at lower Wegovy doses; they show up most while the dose is being raised.
Most of what Wegovy does to your stomach comes down to one thing: it slows how fast your stomach empties. That's also part of how it curbs appetite. So if your gut feels slow, full, or queasy, that's the medicine doing its main job — turned up a notch at 7.2 mg.
| Side effect | Placebo | Wegovy 2.4 mg | Wegovy HD 7.2 mg |
|---|---|---|---|
| Nausea | 13% | 35% | 39% |
| Vomiting | 6% | 16% | 22% |
| Dysesthesia (skin feelings) | 0%* | 6% | 22% |
| Constipation | 8% | 19% | 20% |
| Stomach pain | 7% | 9% | 12% |
| Tiredness | 5% | 9% | 11% |
| Headache | 7% | 8% | 9% |
| Dizziness | 1% | 5% | 6% |
| Hair loss | 1% | 3% | 6% |
| Gas (flatulence) | 2% | 2% | 4% |
Source: FDA-approved Wegovy Prescribing Information, Table 4. Reactions in 2% or more of people on 7.2 mg, and more often than on both 2.4 mg and placebo. “Extra vs 2.4 mg” column is our calculation.
*Table 4 lists placebo dysesthesia as 0%. The label's separate dysesthesia write-up reports placebo at 0.3%. We show both so the numbers match the label exactly.
Wait — where's diarrhea?
Good catch, and it's worth a sentence. Diarrhea is a well-known Wegovy side effect in general. But it's not in the HD table above. That's not a mistake. The FDA's 7.2 mg table only lists side effects that were both common and more frequent at 7.2 mg than at 2.4 mg. Diarrhea didn't clear that specific bar in the head-to-head trials, so it's not listed here — even though it can still happen on any dose. Translation: this table shows you what changes at the higher dose, not everything that might happen.
What side effect changes the most on Wegovy HD?
Dysesthesia changes the most. It's a medical word for altered skin sensations — tingling, burning, pins-and-needles, or skin that feels too sensitive. In FDA trials, 22% of people on Wegovy HD 7.2 mg reported it, compared with 6% on the 2.4 mg dose and 0.3% on placebo. That's about 16 extra reports for every 100 people who step up.
What it can feel like
The FDA label groups these together — burning, tingling, sensitive skin, and skin pain — under the word dysesthesia. People often describe it as a mild “sunburn” feeling with no sunburn, skin that's tender when clothes brush against it, or a buzzing, pins-and-needles sensation. It can come and go.
The label's note
The FDA label notes dysesthesia tends to rise as the dose and drug level in the blood go up. It catches people off guard because nobody warns you about it the way they warn you about nausea.
Does dysesthesia mean you have to stop Wegovy HD?
Not automatically. The FDA label gives us real numbers most articles skip. Among the 288 people in the trials who got dysesthesia on Wegovy HD, here's what happened:
| What they did | Share of 288 people | Outcome |
|---|---|---|
| Stopped the medicine for good | 2% | Permanent discontinuation |
| Paused it for a while | 8% | Most recovered, faster than those who changed nothing |
| Lowered their dose | 23% | Most recovered, faster than those who changed nothing |
| Changed nothing, kept going | Remainder | 18% of all who got dysesthesia had not recovered by trial end |
| Recovered then went back to 7.2 mg | 38 people | 45% (17 of 38) had skin feelings return |
▶ Turn my symptoms into questions for my prescriber. If skin sensations (or anything else) showed up after you stepped up, our quick tool turns what you're feeling into clear questions and a symptom note you can bring to your next visit.
Build my prescriber question list →Are Wegovy HD side effects worse than the 2.4 mg dose?
Mostly no — with one clear exception. The types of side effects are the same as the 2.4 mg dose, and the share of people who quit over side effects was identical: about 5% on each, versus 2% on placebo. The exception is dysesthesia, which jumped from 6% at 2.4 mg to 22% at 7.2 mg. Vomiting also rose, from 16% to 22%.
| Rank | Side effect | Extra per 100 vs 2.4 mg |
|---|---|---|
| 1 | Dysesthesia (skin feelings) | +16 |
| 2 | Vomiting | +6 |
| 3 | Nausea | +4 |
| 4 (tie) | Stomach pain | +3 |
| 4 (tie) | Hair loss | +3 |
| 6 | Tiredness | +2 |
| 7 | Constipation | +1 |
Source: our calculation from FDA Table 4.
The honest tradeoff
Wegovy HD is not just “regular Wegovy, but better.” The 7.2 mg dose clearly raised the rate of skin sensations and bumped up vomiting. If you are already struggling to get through your days on the 2.4 mg dose, going higher may make the gut symptoms harder — and the higher dose may not be your next move yet.
But if you tolerated 2.4 mg fine and your weight loss stalled, that's a different story. In the STEP UP trial, people on Wegovy HD lost about 18.7% of their body weight on average over 72 weeks, versus about 15% on the 2.4 mg dose and about 3.9% on placebo. And about 1 in 3 people on 7.2 mg lost 25% or more of their starting weight — roughly double the share on the standard dose. The step-up is a real conversation to have with your prescriber.
When should Wegovy HD side effects send you to a doctor?
Get urgent help for symptoms that are severe, sudden, or won't stop — especially severe stomach pain (particularly if it spreads to your back), repeated vomiting with signs of dehydration, signs of an allergic reaction, or low-blood-sugar symptoms.
| Possible problem | Signs to take seriously | Why it matters |
|---|---|---|
| Pancreas inflammation (pancreatitis) | Severe, lasting belly pain, sometimes spreading to the back, with or without vomiting | The label lists acute pancreatitis as a warning; it can be serious |
| Gallbladder trouble | Pain in the upper-right belly, fever, yellow skin or eyes, pale stools | Gallstones and gallbladder inflammation happen more often on Wegovy |
| Kidney strain from dehydration | A lot of vomiting or diarrhea, can't keep fluids down, very little urine, dizziness | Heavy fluid loss can hurt the kidneys; the label has reports of this |
| Serious allergic reaction | Swelling of face, lips, tongue, or throat; trouble breathing; severe rash or hives | Anaphylaxis and angioedema have been reported — this is a 911 situation |
| Severe stomach reactions | Severe or non-stop GI symptoms | Wegovy is not recommended if you have severe gastroparesis |
| Low blood sugar | Shaking, sweating, confusion, fast heartbeat, weakness — mostly if you also use insulin or a sulfonylurea | Wegovy lowers blood sugar; that risk goes up with certain diabetes meds |
| Vision changes | New or worsening eyesight problems, mainly if you have type 2 diabetes | The label warns about diabetic retinopathy complications |
| Surgery or sedation coming up | Any planned procedure with anesthesia or deep sedation | Wegovy slows stomach emptying — tell your surgeon and anesthesia team |
Source: FDA-approved Wegovy Prescribing Information, Warnings and Precautions.
Call 911 or go to the ER now if you have:
- • Swelling of face, lips, tongue, or throat
- • Trouble breathing
- • Severe, non-stop belly pain (spreading to your back) with vomiting
- • Chest pain
- • Signs of a serious blood-sugar crash
Call your prescriber soon if you have:
- • A lump or swelling in your neck, hoarseness, or trouble swallowing
- • Vomiting or diarrhea with signs of dehydration
- • Skin sensations spreading, or coming with weakness or numbness
- • New vision changes (if you have diabetes)
What to write down before you call
A two-minute note makes your appointment ten times more useful:
- •Date of your first 7.2 mg dose
- •Your old dose and how long you were on it
- •When the symptom started, and severity (0–10)
- •How many times you’ve vomited, and if you can keep fluids down
- •Where any belly pain is
- •How to describe any skin feelings
- •Your other meds (especially diabetes meds)
- •Any surgery coming up, or pregnancy plans
Wegovy HD Side-Effect Discussion Builder
Answer a few quick questions about your dose, symptoms, and history. You'll get a printable, personalized question list for your prescriber. This tool does not diagnose you, does not replace your doctor, and does not prescribe anything.
Where are you right now with Wegovy?
Who is Wegovy HD actually for — and who should skip it?
Wegovy HD is a step-up dose, not a starting dose. The FDA label says adults using Wegovy for weight loss may move up to 7.2 mg only after handling the 2.4 mg dose for at least 4 weeks, and only when more weight loss is medically needed.
Who should NOT take Wegovy HD (or any Wegovy dose)
The FDA label says Wegovy is off-limits if you have:
- ⚠A personal or family history of medullary thyroid carcinoma (MTC) — a specific type of thyroid cancer
- ⚠Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) — a rare inherited condition that raises that cancer risk
- ⚠A past serious allergic reaction to semaglutide (the drug in Wegovy)
Wegovy also carries a boxed warning about thyroid C-cell tumors. In animal studies, semaglutide caused these tumors; it's not known whether it does in people. Tell your prescriber if you notice a neck lump, hoarseness, or trouble swallowing.
Who needs extra caution before stepping up
Bring these up before moving to 7.2 mg:
- △History of pancreatitis or gallbladder disease
- △Kidney concerns, or you get dehydrated easily
- △Type 2 diabetes with eye disease (diabetic retinopathy)
- △A surgery or procedure with anesthesia coming up
- △Severe gastroparesis (very slow stomach) -- Wegovy isn't recommended here
- △Pregnancy, or plans to get pregnant -- stop Wegovy at least 2 months before trying
The safety of the 7.2 mg dose has not been established in children/teens or in people with MASH (metabolic dysfunction-associated steatohepatitis). Don't assume lower-dose data applies there.
How long do Wegovy HD side effects last?
There's no single timeline, and anyone who promises one is guessing. The gut side effects are usually worst while your dose is climbing and often ease as your body adjusts. But the FDA's dysesthesia data shows recovery varies: most people who paused, lowered, or stopped the dose recovered, while 18% of those who got skin sensations had not recovered by the end of the trial.
For the skin sensations specifically, the label is clear that taking action helps. People who paused, lowered, or stopped the dose mostly recovered — and recovered faster than people who changed nothing. Of those who got skin feelings and just kept going at the same dose, a meaningful share hadn't recovered by the trial's end.
Instead of watching the calendar, ask your prescriber:
- • How bad does a symptom need to be before I message you same-day?
- • How long is “too long” before I check back in?
- • What signs mean “don't take the next dose until we talk”?
- • Do my health conditions change any of those answers?
What can you do about nausea, vomiting, or constipation?
Don't change your Wegovy dose on your own — that's a prescriber decision. For nausea, vomiting, or constipation, the safest move is to track how bad it is, when it happens, your fluids, and whether it's getting better or worse, then call your clinician if it's severe, won't stop, or is leaving you dehydrated.
| Symptom | What tends to help | When to call your prescriber |
|---|---|---|
| Nausea | Smaller meals, eat slower, go easy on greasy/fatty food, sip fluids | You can't keep fluids down |
| Constipation | More water, more fiber, gentle movement | No relief in several days, or severe pain |
| Vomiting / diarrhea | Hydrate steadily, stick to bland foods | Signs of dehydration, or it just won't stop |
| Tiredness or headache | Sleep, fluids, regular meals | Severe or hanging on for weeks |
How much does Wegovy HD cost, and where do you actually get it?
For self-pay, NovoCare lists the Wegovy HD 7.2 mg pen at $399 per month. NovoCare's coverage tool currently says there is no insurance coverage for Wegovy injection 7.2 mg — so treat HD as a self-pay path for now.
| Where / how | What we found | Verified |
|---|---|---|
| Self-pay via NovoCare Pharmacy | Wegovy HD 7.2 mg pen: $399/month | |
| Insurance for Wegovy HD 7.2 mg | NovoCare's checker says no insurance coverage available for the 7.2 mg dose right now — self-pay only | |
| Insurance for standard Wegovy doses | Copay as low as $25/month with the savings offer if your plan covers it (government plans excluded; terms can change) | |
| GoodRx | Wegovy HD self-pay listed at $399/month for eligible patients | |
| Telehealth (e.g., Ro) | FDA-approved Wegovy access + a free GLP-1 insurance coverage checker; confirm current HD availability in the provider's flow | |
| Pharmacies | Available through about 70,000 US pharmacies, NovoCare Pharmacy, and select telehealth providers |
Does insurance cover Wegovy HD 7.2 mg?
Right now, NovoCare's coverage checker says no insurance coverage is available for Wegovy injection 7.2 mg. That makes Wegovy HD mainly a self-pay conversation for now. Standard Wegovy doses may still have separate commercial insurance and savings-card options, so if cost is the blocker, a lower dose plus coverage may be worth asking your prescriber about.
Ro is one of Novo Nordisk's telehealth partners for FDA-approved Wegovy and offers a free GLP-1 insurance coverage check. Because Wegovy HD is an FDA-approved brand, the right path is a provider that handles FDA-approved Wegovy — not a compounded knock-off. Note that HD has no insurance coverage at the moment, so confirm current Wegovy HD availability and self-pay pricing in Ro's flow before you count on it.
FDA-Approved Access
Check FDA-approved Wegovy access options
Best for readers who need a licensed prescriber or want to check coverage for FDA-approved Wegovy. For the 7.2 mg HD dose specifically, verify current self-pay availability first. If you're having a red-flag symptom from the list above, get medical help first — access can wait.
Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
Check Wegovy coverage on Ro → (sponsored affiliate link, opens in a new tab)Is there a compounded or generic version of Wegovy HD?
No. Wegovy HD (7.2 mg) is an FDA-approved, brand-name medicine made by Novo Nordisk. There is no FDA-approved generic, and there is no legitimate “compounded Wegovy HD.” Compounded semaglutide is now tightly restricted: the FDA declared the semaglutide injection shortage resolved in February 2025, and in 2026 proposed limiting it further.
| Question | Answer |
|---|---|
| Is there an FDA-approved Wegovy HD 7.2 mg? | Yes |
| Is there an FDA-approved generic of it? | No |
| Is there a legitimate compounded “Wegovy HD”? | No |
| Can pharmacies still freely compound semaglutide? | The FDA declared the semaglutide injection shortage resolved on Feb 21, 2025, which removed the main basis for making copies of an available drug |
| What changed in 2026? | In April 2026, the FDA proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulk-compounding list |
Source: FDA statements on GLP-1 compounding (2025–2026).
Wegovy HD side effects: quick answers
Standalone answers to the questions people ask most about the 7.2 mg dose.
Is dysesthesia common with Wegovy HD?
Yes. In FDA trials, 22% of people on Wegovy HD 7.2 mg reported dysesthesia (skin sensations like tingling or burning), versus 6% on the 2.4 mg dose and 0.3% on placebo in the label's dysesthesia section. Report new, spreading, painful, or persistent skin sensations to your prescriber.
Does Wegovy HD cause more nausea than the regular dose?
A little. Nausea was reported by 39% of people on Wegovy HD versus 35% on the 2.4 mg dose. Nausea is common on any dose, but the bigger jump at 7.2 mg is the skin sensations, not nausea.
Does Wegovy HD cause more vomiting?
Yes. Vomiting was reported by 22% on Wegovy HD versus 16% on the 2.4 mg dose. Repeated vomiting matters because heavy fluid loss can strain the kidneys, so do not ignore it if it is persistent.
Can Wegovy HD cause hair loss?
Hair loss was reported by about 6% of people on Wegovy HD versus 3% on the 2.4 mg dose; the label notes it was associated with weight reduction. It is worth mentioning to your prescriber if it appears after you step up.
Can I start straight on Wegovy HD 7.2 mg?
No. It is not a starting dose. The FDA label says adults may move up to 7.2 mg only after handling the 2.4 mg dose for at least 4 weeks and when more weight loss is medically needed.
Is Wegovy HD approved for teenagers?
The FDA label says the safety of the 7.2 mg dose has not been established in children or teens. The data for the lower 2.4 mg dose in adolescents should not be treated as approval for the HD dose.
Can I take Wegovy HD with Ozempic, Rybelsus, or another GLP-1?
No. The FDA label says Wegovy should not be used with other semaglutide products or any other GLP-1 medicine, including combining products to copy a dose change.
Does insurance cover Wegovy HD 7.2 mg?
Currently, NovoCare's coverage checker says no insurance coverage is available for Wegovy injection 7.2 mg, so it is mainly a self-pay option for now at about $399 per month. Standard Wegovy doses may still have separate commercial insurance and savings-card options.
How do I report a Wegovy HD side effect?
You can report side effects to Novo Nordisk at 1-833-934-6891 or to the FDA MedWatch program at 1-800-FDA-1088 or fda.gov/medwatch.
Still deciding? Here's your next step.
If you're having severe, sudden, or worrying symptoms, your next step isn't another article — it's a message to your clinician or a trip to urgent care. If you're not in distress and you're weighing whether to step up, use the discussion builder above and bring it to your prescriber.
Still not sure which GLP-1 program is right for you?
Take our free 60-second GLP-1 matching quiz →Related guides
Sources
- FDA-approved Wegovy (semaglutide) Prescribing Information, revised 03/2026. accessdata.fda.gov (215256s029lbl.pdf)
- STEP UP phase 3b trial (Wharton et al., American Diabetes Association Scientific Sessions, June 2025).
- NovoCare Wegovy pricing. novocare.com/patient/medicines/wegovy.html
- NovoCare Wegovy coverage tool. novocare.com/patient/medicines/wegovy/check-coverage.html
- GoodRx Wegovy HD announcement (Apr 2026).
- FDA statements on GLP-1 compounding (2025–2026). fda.gov GLP-1 compounding statement
Disclosure: Some links on this page are affiliate links, marked as such. If you start care through one, we may earn a commission at no extra cost to you. See our affiliate disclosure for details. This page is educational information, not medical advice. Side-effect figures come from the FDA-approved Wegovy Prescribing Information (revised March 2026).